BrightFocus Foundation

Explore How BrightFocus Foundation is Working to End Mind and Sight Diseases Through the Power of Research

Global nonprofit has nearly 300 active grants across the globe to defeat Alzheimer’s disease, glaucoma, and macular degeneration.
  • Research News
Published on:
Four scientists in a group photo wearing their lab coats.

Newly released research portfolios highlight the 276 biomedical research projects funded by BrightFocus Foundation across 16 countries to defeat Alzheimer’s disease, macular degeneration, and glaucoma. 

BrightFocus Foundation, through its programs Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research, is currently supporting more than 900 scientists pursuing the most innovative methods to diagnose, treat, and prevent these diseases of mind and sight.  

The Foundation’s grant awards are selected by its Scientific Review Committee, comprising leading scientists and clinicians who recommend projects reflecting the most cutting-edge and impactful research in the field. This reflects the Foundation’s funding philosophy of following the most innovative and promising ideas and proposals that will further our understanding and advance cures for Alzheimer’s, macular degeneration, and glaucoma.

Alzheimer’s Disease Research 

With support from Alzheimer’s Disease Research, scientists are tackling the disease from many angles, investigating how complex systems in the body interact with the brain to develop earlier detection strategies and novel treatments. Our 157 active Alzheimer’s grants offer great promise and opportunity to defeat this heartbreaking disease. 

View the Alzheimer’s Disease Research Portfolio in magazine format or view a printable format (PDF)

Macular Degeneration Research

Macular Degeneration Research is funding 58 research projects on the causes and potential prevention, treatment, and cure of macular degeneration. From studies exploring the influence of early life events, diet, and lifestyle on macular degeneration to a disease-in-a-dish approach to screening for FDA-approved drugs that could be used to treat macular degeneration, we have invested in several promising avenues of research that cover a broad array of innovative scientific approaches.

View the Macular Degeneration Research Portfolio in magazine format or view a printable format (PDF). 

National Glaucoma Research

National Glaucoma Research is supporting 61 scientific projects exploring the root causes and prevention strategies and treatments to end glaucoma. With our funding, researchers are advancing newer imaging techniques and strategies for early detection, exploring exercise to slow vision loss, and finding new ways to control eye pressure—taking a 360-degree approach to ending this disease.

View the National Glaucoma Research Portfolio in magazine format or view a printable format (PDF). 

About BrightFocus Foundation      

BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, National Glaucoma Research, and Macular Degeneration Research — the Foundation has awarded nearly $290 million in groundbreaking research funding over the past 50 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at

Don't miss out.

Receive breakthrough news, updates, and inspiring stories on Alzheimer's disease, macular degeneration, and glaucoma research.